Allergan recalls eye drugs after patients complain of particles, blurred vision

Carly Helfand

Since and Actavis joined hands to become a new-look , the company has already had to recall a from the Actavis side. Now, it's recalling one from the side, putting a call out for certain lots of eye-treatment ointments sold in the U.S.–and it's already received some consumer complaints.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS